These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 9576621)

  • 1. Genetic influence on disease course and cytokine response in relapsing experimental allergic encephalomyelitis.
    Kjellén P; Issazadeh S; Olsson T; Holmdahl R
    Int Immunol; 1998 Mar; 10(3):333-40. PubMed ID: 9576621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic analysis of inflammation, cytokine mRNA expression and disease course of relapsing experimental autoimmune encephalomyelitis in DA rats.
    Lorentzen JC; Andersson M; Issazadeh S; Dahlman I; Luthman H; Weissert R; Olsson T
    J Neuroimmunol; 1997 Dec; 80(1-2):31-7. PubMed ID: 9413257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasal administration of myelin basic protein prevents relapsing experimental autoimmune encephalomyelitis in DA rats by activating regulatory cells expressing IL-4 and TGF-beta mRNA.
    Bai XF; Shi FD; Xiao BG; Li HL; van der Meide PH; Link H
    J Neuroimmunol; 1997 Dec; 80(1-2):65-75. PubMed ID: 9413260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokines in relapsing experimental autoimmune encephalomyelitis in DA rats: persistent mRNA expression of proinflammatory cytokines and absent expression of interleukin-10 and transforming growth factor-beta.
    Issazadeh S; Lorentzen JC; Mustafa MI; Höjeberg B; Müssener A; Olsson T
    J Neuroimmunol; 1996 Sep; 69(1-2):103-15. PubMed ID: 8823381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strain variation in autoimmunity: attempted tolerization of DA rats results in the induction of experimental autoimmune encephalomyelitis.
    Lenz DC; Wolf NA; Swanborg RH
    J Immunol; 1999 Aug; 163(4):1763-8. PubMed ID: 10438907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High interleukin-10 expression within the central nervous system may be important for initiation of recovery of Dark Agouti rats from experimental autoimmune encephalomyelitis.
    Blaževski J; Petković F; Momčilović M; Jevtic B; Miljković D; Mostarica Stojković M
    Immunobiology; 2013 Sep; 218(9):1192-9. PubMed ID: 23664544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99.
    Liu JQ; Bai XF; Shi FD; Xiao BG; Li HL; Levi M; Mustafa M; Wahren B; Link H
    Int Immunol; 1998 Aug; 10(8):1139-48. PubMed ID: 9723700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The major histocompatibility complex influences myelin basic protein 63-88-induced T cell cytokine profile and experimental autoimmune encephalomyelitis.
    Mustafa M; Vingsbo C; Olsson T; Ljungdahl A; Höjeberg B; Holmdahl R
    Eur J Immunol; 1993 Dec; 23(12):3089-95. PubMed ID: 7504988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of ongoing experimental allergic encephalomyelitis (EAE) in Lewis rats: synergistic effects of myelin basic protein (MBP) peptide 68-86 and IL-4.
    Xu LY; Huang YM; Yang JS; Van Der Meide PH; Link H; Xiao BG
    Clin Exp Immunol; 2000 Jun; 120(3):526-31. PubMed ID: 10844533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral administration of cholera toxin B subunit conjugated to myelin basic protein protects against experimental autoimmune encephalomyelitis by inducing transforming growth factor-beta-secreting cells and suppressing chemokine expression.
    Sun JB; Xiao BG; Lindblad M; Li BL; Link H; Czerkinsky C; Holmgren J
    Int Immunol; 2000 Oct; 12(10):1449-57. PubMed ID: 11007763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of experimental allergic encephalomyelitis in rats by targeting autoantigen to B cells: evidence that the protective mechanism depends on changes in the cytokine response and migratory properties of the autoantigen-specific T cells.
    Saoudi A; Simmonds S; Huitinga I; Mason D
    J Exp Med; 1995 Aug; 182(2):335-44. PubMed ID: 7543135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protracted, relapsing and demyelinating experimental autoimmune encephalomyelitis in DA rats immunized with syngeneic spinal cord and incomplete Freund's adjuvant.
    Lorentzen JC; Issazadeh S; Storch M; Mustafa MI; Lassman H; Linington C; Klareskog L; Olsson T
    J Neuroimmunol; 1995 Dec; 63(2):193-205. PubMed ID: 8550817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon gamma, interleukin 4 and transforming growth factor beta in experimental autoimmune encephalomyelitis in Lewis rats: dynamics of cellular mRNA expression in the central nervous system and lymphoid cells.
    Issazadeh S; Mustafa M; Ljungdahl A; Höjeberg B; Dagerlind A; Elde R; Olsson T
    J Neurosci Res; 1995 Apr; 40(5):579-90. PubMed ID: 7602612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic susceptibility or resistance to autoimmune encephalomyelitis in MHC congenic mice is associated with differential production of pro- and anti-inflammatory cytokines.
    Maron R; Hancock WW; Slavin A; Hattori M; Kuchroo V; Weiner HL
    Int Immunol; 1999 Sep; 11(9):1573-80. PubMed ID: 10464178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curative effects of recombinant human Interleukin-6 in DA rats with protracted relapsing experimental allergic encephalomyelitis.
    Di Marco R; Khademi M; Wallstrom E; Iacobaeus E; Salvaggio A; Caracappa S; Papoian R; Nicoletti F; Olsson T
    J Neuroimmunol; 2001 Jun; 116(2):168-77. PubMed ID: 11438171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Essential role of TGF-beta in the natural resistance to experimental allergic encephalomyelitis in rats.
    Cautain B; Damoiseaux J; Bernard I; van Straaten H; van Breda Vriesman P; Boneu B; Druet P; Saoudi A
    Eur J Immunol; 2001 Apr; 31(4):1132-40. PubMed ID: 11298338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major histocompatibility complex-controlled protective influences on experimental autoimmune encephalomyelitis are peptide specific.
    Issazadeh S; Kjellén P; Olsson T; Mustafa M; Holmdahl R
    Eur J Immunol; 1997 Jun; 27(6):1584-7. PubMed ID: 9209515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic control of the development of experimental allergic encephalomyelitis in rats. Separation of MHC and non-MHC gene effects.
    Happ MP; Wettstein P; Dietzschold B; Heber-Katz E
    J Immunol; 1988 Sep; 141(5):1489-94. PubMed ID: 2457618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
    Zheng H; Zhang H; Liu F; Qi Y; Jiang H
    Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective influences on experimental autoimmune encephalomyelitis by MHC class I and class II alleles.
    Mustafa M; Vingsbo C; Olsson T; Issazadeh S; Ljungdahl A; Holmdahl R
    J Immunol; 1994 Oct; 153(7):3337-44. PubMed ID: 7522259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.